Table 2. Metabolites significantly associated with treatment T+E.
ID | Name | W0 vs. W1 | W0 vs. W4 | W0 vs. W7 | W0 vs. W9 | Variation | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
p-valuea | q-value BHb | Fold Change | p-valuea | q-value BHb | Fold Change | p-valuea | q-value BHb | Fold Change | p-valuea | q-value BHb | Fold Change | |||
1 | Acetate | 0.003 | 0.038 | 0.73 | 0.003 | 0.019 | 0.71 | 0.001 | 0.006 | 0.66 | ↓ | |||
2 | Acetoacetate | 0.009 | 0.042 | 0.84 | 0.001 | 0.009 | 0.79 | 0.001 | 0.023 | 0.83 | ↓ | |||
3 | Acetone | 0.0006 | 0.025 | 1.27 | 0.0001 | 0.002 | 1.44 | 0.0001 | 0.002 | 1.39 | ↑ | |||
4 | Alanine | 0.001 | 0.032 | 0.83 | 0.001 | 0.010 | 0.80 | 0.001 | 0.006 | 0.81 | ↓ | |||
5 | Albumin Lysyl | 0.002 | 0.038 | 0.83 | 0.00004 | 0.002 | 0.77 | 0.0006 | 0.006 | 0.81 | ↓ | |||
6 | Betaine | 0.004 | 0.038 | 0.82 | 0.0003 | 0.005 | 0.76 | 0.002 | 0.012 | 0.77 | ↓ | |||
7 | Choline | 0.007 | 0.040 | 0.88 | 0.003 | 0.016 | 0.86 | ↓ | ||||||
8 | Citrate | 0.002 | 0.015 | 0.80 | ↓ | |||||||||
9 | Creatine | 0.001 | 0.032 | 0.83 | 0.00001 | 0.001 | 0.78 | 0.000001 | 0.00001 | 0.76 | ↓ | |||
10 | Creatinine | 0.00002 | 0.002 | 0.86 | 0.000002 | 0.0003 | 0.78 | 0.000001 | 0.00001 | 0.76 | ↓ | |||
11 | Fatty acids | 0.0006 | 0.025 | 1.27 | 0.010 | 0.046 | 1.23 | 0.001 | 0.009 | 1.32 | 0.003 | 0.041 | 1.12 | ↑ |
12 | Fatty acids (mainly LDL) | 0.002 | 0.015 | 1.32 | 0.001 | 0.006 | 1.37 | ↑ | ||||||
13 | Fatty acids (mainly VLDL) | 0.002 | 0.015 | 1.35 | 0.002 | 0.012 | 1.35 | ↑ | ||||||
14 | Glucose | 0.002 | 0.018 | 0.86 | 0.0002 | 0.004 | 0.82 | 0.0003 | 0.013 | 0.84 | ↓ | |||
15 | Glycerol backbone of PGLYs & TAGs | 0.003 | 0.019 | 1.15 | 0.001 | 0.006 | 1.21 | 0.0001 | 0.013 | 1.20 | ↑ | |||
16 | Glycerophosphocholine | 0.007 | 0.040 | 0.82 | 0.001 | 0.006 | 0.79 | ↓ | ||||||
17 | Histidine | 0.004 | 0.040 | 0.85 | 0.0003 | 0.005 | 0.82 | 0.0004 | 0.006 | 0.78 | ↓ | |||
18 | Isoleucine | 0.008 | 0.035 | 0.85 | ↓ | |||||||||
19 | Lysine | 0.001 | 0.032 | 0.85 | 0.001 | 0.008 | 0.81 | 0.0001 | 0.002 | 0.79 | ↓ | |||
20 | Mannose | 0.009 | 0.036 | 1.30 | ↑ | |||||||||
21 | Methanol | 0.002 | 0.016 | 0.80 | 0.001 | 0.008 | 0.78 | ↓ | ||||||
22 | Myo-inositol | 0.0001 | 0.003 | 0.78 | 0.0001 | 0.002 | 0.75 | ↓ | ||||||
23 | NAC 1 | 0.002 | 0.011 | 1.10 | 0.0003 | 0.013 | 1.15 | ↑ | ||||||
24 | Phenylalanine | 0.0003 | 0.019 | 0.64 | 0.0003 | 0.005 | 0.58 | 0.001 | 0.008 | 0.63 | 0.002 | 0.037 | 0.59 | ↓ |
25 | Proline | 0.001 | 0.008 | 0.78 | ↓ | |||||||||
26 | Tyrosine | 0.002 | 0.038 | 0.83 | 0.00001 | 0.001 | 0.74 | 3 × 10 -8 | 0.00001 | 0.67 | 0.0002 | 0.012 | 0.78 | ↓ |
27 | Valine | 0.004 | 0.038 | 0.81 | 0.010 | 0.046 | 0.89 | 0.00002 | 0.0008 | 0.70 | 0.004 | 0.044 | 0.86 | ↓ |
a p-value without multiple testing correction.
b q-value BH: p-value after Benjamini-Hochberg false discovery rate multiple testing correction. Variation: ↑ corresponds to higher concentration in W1, W4, W7 or W9 serum metabolic profiles than at baseline; ↓ to lower concentration in W1, W4, W7 or W9 serum metabolic profiles than at baseline.